Evidence map›Paper›PMID 40615973›Full record

ArticleBMC pulmonary medicine2025

İlteriş Türk, Mehmet Çetin, Necati Solak, Ali Can Kayaaslan, Nesrin Gürçay, Ebru Tatcı, Göktürk Fındık, Pınar Bıçakçıoğlu, Selim Şakir Erkmen Gülhan

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

İlteriş TürkDepartment of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye. turkilteris@gmail.com.ORCID http://orcid.org/0000-0001-6385-4722
Mehmet ÇetinDepartment of Thoracic Surgery, Ankara Etlik City Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0001-5471-2239
Necati SolakDepartment of Thoracic Surgery, Ankara Etlik City Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0003-1046-5410
Ali Can KayaaslanDepartment of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye.ORCID http://orcid.org/0009-0000-8775-2181
Nesrin GürçayDepartment of Pathology, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-6067-7342
Ebru TatcıDepartment of Nuclear Medicine, Ankara Etlik City Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-9216-658X
Göktürk FındıkDepartment of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-8861-7608
Pınar BıçakçıoğluDepartment of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-7058-6508
Selim Şakir Erkmen GülhanDepartment of Thoracic Surgery, University of Health Sciences, Atatürk Sanatoryum Training and Research Hospital, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-1143-9655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have been conducted to identify the parameters associated with the aggressive course of pleuropulmonary solitary fibrous tumors (SFT) following surgical treatment, and various classification systems have been proposed for assessing risk.

methodsThe surgical outcomes of patients with pleuropulmonary SFT who underwent surgery between 2009 and 2024 at our center were retrospectively evaluated. Parameters of patients who experienced recurrence during follow-up were analyzed, and the risk classification systems proposed by Demicco were tested on our patient cohort. The pozitron emision tomography/ computed tomography (PET/CT) standart uptake value(SUVmax), which was significantly associated with recurrence, was incorporated into the modified Demicco classification, and a new classification model was developed and compared with existing models.

resultsAmong the 79 included patients, 21.5% had intraparenchymal tumors, which were excised along with various parenchymal resections, while pleural tumors underwent mass excision. The postoperative follow-up period was 108.16 ± 44.09 months, during which 7.6% of patients experienced recurrence. Tumor size (p = 0.023), mitotic index (p < 0.001), presence of necrosis (p = 0.007), and PET/CT SUVmax value (p = 0.005) were found to be significantly associated with recurrence. The PET/CT SUVmax value, which was not included in Demicco's classifications, ranged from 1.12 to 7.98, with a cutoff value of 4.50. The addition of SUVmax to the modified Demicco classification categorized all patients with recurrence into the high-risk group, and the new classification model strongly differentiated recurrence (p < 0.01, 100% sensitivity, 71.43% specificity).

conclusionThe incorporation of SUVmax into the modified Demicco classification system for pleuropulmonary SFT provides a more significant prediction of recurrence.

Indexed as

Lung NeoplasmsNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographySolitary Fibrous Tumor, PleuralSolitary Fibrous TumorsAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesRisk AssessmentFluorodeoxyglucose F18RadiopharmaceuticalsRecurrenceSolitary fibrous tumorSurgerySUVmax

Identifiers

PMID40615973
PMCPMC12231890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.